<DOC>
	<DOCNO>NCT01137630</DOCNO>
	<brief_summary>Seborrhoeic dermatitis ( SD ) papulosquamous ( presence papule scale ) disorder pattern sebum-rich area scalp , face , trunk . The current treatment cure disease permanently . Therefore must repeat symptom recur , even prophylactically . Corticosteroids antifungal mainstay therapy . Topical corticosteroid rapidly reduce cutaneous sign disease , associate high frequency relapse treatment stop . They reserve acute flare-up may precipitate recurrence dependence . In addition , chronic use corticosteroid associate side-effects . The scientific rationale use K40 treatment SD base clinical evidence K40 improve erythema desquamation mild adverse reaction case . The primary objective study evaluate efficacy K40 ( K40a K40b combine ) compare placebo 4 week treatment measure sum erythema desquamation score Week 4 .</brief_summary>
	<brief_title>Two Topical K40 Formulations Adults With Seborrhoeic Dermatitis ( SD ) Scalp</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Seborrheic</mesh_term>
	<criteria>Male female ( include fertile woman ) 1865 year age Seborrhoeic dermatitis scalp least 2 month Presenting erythema desquamation mild , moderate , pronounce severe intensity Signed write informed consent Patient antifungal , selenium sulphite corticosteroid therapy within last 2 week prior start study treatment Any cutaneous disease face require specific topical treatment ( corticosteroid , antifungal , antibiotic , retinoids , benzoyl peroxide ahydroxyacids ) previous 15 day Oral treatment cyclines , lithium , antifungal inhale corticosteroid previous month Use systemic corticosteroid retinoids previous 2 month SD associate Parkinson 's disease , human immunodeficiency virus infection Current history ear , nose throat carcinoma , Current history severe concomitant disease accord Investigator'sjudgement Allergy test treatment component</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>seborrhoeic dermatitis</keyword>
	<keyword>scalp</keyword>
	<keyword>K40a</keyword>
	<keyword>K40b</keyword>
</DOC>